PARIS, France, May 22th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high... | May 22, 2023

Related Keywords

United States ,France ,Paris ,France General ,Hugo Brugi ,Fabreguettes Leib ,Schwartz ,Edison Group ,Edison Investment Research ,January Neovacs ,Euronext Growth ,Presse Financi ,Pharnext Sa Stock Exchange ,News ,Information ,Press Release ,Bay ,M ,Pet ,Pharnext ,Ca ,N ,Dvanced ,Stage ,Iopharmaceutical ,Company ,Developing ,Novel ,Herapeutics ,Or ,Neurodegenerative ,Diseases ,Ith Alpha Fr001400gun7 ,